Buy-Now-Pay-Later Debt Is Becoming Invisible to the Credit System
Buy-now-pay-later services have expanded from checkout-page...
Regulators Are Scrutinizing How Deeply Banks Are Tied to Private Credit
Private credit has grown into a multi-trillion-dollar industry largely outside bank-style oversight, and regulators are now examining just how deeply traditional banks are financially linked to it.
Immigration Is Quietly Propping Up Labor Force Growth in Aging Economies
Immigration is now a major driver of labor force growth in aging economies, and economists broadly see it as a net positive — even as it remains one of the most politically divisive issues around.
Why Global Supply Chains Are Quietly Being Rebuilt
Years of trade tension and pandemic-era shortages have pushed manufacturers to diversify supply chains away from single-country dependence — a costly shift now showing up clearly in trade data.
How Much Government Debt Is Actually Too Much?
Government debt keeps climbing across major economies, and interest payments alone are consuming a growing share of national budgets — fueling debate over how much more borrowing room remains.
Why Youth Unemployment Is Rising Even as Overall Job Numbers Hold Steady
Overall employment looks stable, but youth unemployment is rising sharply as entry-level roles — the traditional training ground for new graduates — are increasingly handed to AI tools instead.
Central Banks Are Split on How Fast to Keep Cutting Rates
Inflation has cooled from its peak, but central bankers remain divided on how fast to keep cutting rates — and many households say prices still haven't come back down.
Gene Editing Just Restored Hearing and Vision in Early Clinical Trials
Gene-editing trials have restored hearing and slowed inherited vision loss in early patients, marking some of the technology's first tangible medical wins outside the lab.
Solid-State Batteries Are Finally Leaving the Lab
Solid-state batteries have promised faster charging and longer range for years. Pilot production lines are finally testing whether the chemistry can scale beyond the lab.
Global Renal Diseases Market Will Reach US$ 267.48 Billion by 2034
The Renal Diseases Market is witnessing substantial growth as the prevalence of chronic kidney disease, acute kidney injury, diabetic nephropathy, and other renal disorders continues to increase worldwide. Rising incidences of diabetes, hypertension,…